Cointime

Frequency Therapeutics

company

About

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

  • 51 - 100

Highlights

Total Funding Amount
$74.30M
Funding Rounds
4
Investors
3

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$42.30M
Industries
Biotechnology,Genetics,Medical
Founded date
Jan 1, 2015
Number Of Employee
51 - 100
Operating Status
Active

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering.

It was founded in 2015 and headquartered in Woburn, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$74.30M
Frequency Therapeutics has raised a total of $74.30M in funding over 2 rounds. Their latest funding was raised on Jul 17, 2020 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 17, 2020 Post-IPO Equity $42.30M 1 — — Detail
Jul 23, 2019 Series C — 1 — — Detail
Jan 7, 2019 Series B — 1 — — Detail
Apr 11, 2017 Series A $32M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
3
Frequency Therapeutics is funded by 3 investors. Maven Investment Partners US and Polaris Founders Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Maven Investment Partners US — Post-IPO Equity
Polaris Founders Capital — Series C
Emigrant Capital — Series B
Cointime
เนื้อหา
บริษัท